Möchten Sie immer auf dem neuesten Stand bleiben?
Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.
-
STOCKHOLM, Sweden and SAN DIEGO, Sept. 20, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) today announced that its confirmatory Phase 3 trial (M104) of the investigational drug...
-
STOCKHOLM, Sweden and SAN DIEGO, Aug. 3, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals, Inc. (Nasdaq:MAXM) (SSE:MAXM) today announced results for the quarter ended June 30, 2004, the third quarter of its...
-
STOCKHOLM, Sweden and SAN DIEGO, July 27, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) today announced the appointment of Richard A. Mafrica, 47, to the newly created position...
-
SAN DIEGO, June 29, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced that its stock has been added to the Russell 2000 Index. The annual reconstitution of Russell's 21...
-
SAN DIEGO, May 25, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) today announced that it has been added to the NASDAQ Biotechnology Index(r) (NBI). All securities in the Index...
-
STOCKHOLM, Sweden, May 20, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals, Inc. (Nasdaq:MAXM) (SSE:MAXM) announced that the Plaintiff in the Company's federal class action securities complaint has dropped...
-
SAN DIEGO and STOCKHOLM, Sweden, May 18, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) today announced preclinical results demonstrating the ability of histamine to prevent...
-
San Diego, Calif. and STOCKHOLM, Sweden, May 12, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) today announced the results of an international Phase 3 clinical trial testing the...
-
SAN DIEGO, Calif., and STOCKHOLM, Sweden, May 4, 2004 (PRIMEZONE) -- Maxim Pharmaceuticals, Inc. (Nasdaq:MAXM) (SSE:MAXM) today announced results for the quarter ended March 31, 2004, the second...
-
SAN DIEGO, April 19, 2004 - Maxim Pharmaceuticals (Nasdaq:MAXM) (SSE:MAXM) announced preclinical results indicating that histamine may prevent lipopolysaccharide (LPS)-induced liver injury. The...